Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3727440
Max Phase: Preclinical
Molecular Formula: C16H28O2
Molecular Weight: 252.40
Molecule Type: Small molecule
Associated Items:
ID: ALA3727440
Max Phase: Preclinical
Molecular Formula: C16H28O2
Molecular Weight: 252.40
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C1CCCCC/C=C\CCCCCCCCO1
Standard InChI: InChI=1S/C16H28O2/c17-16-14-12-10-8-6-4-2-1-3-5-7-9-11-13-15-18-16/h2,4H,1,3,5-15H2/b4-2-
Standard InChI Key: NVIPUOMWGQAOIT-RQOWECAXSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 252.40 | Molecular Weight (Monoisotopic): 252.2089 | AlogP: 4.78 | #Rotatable Bonds: 0 |
Polar Surface Area: 26.30 | Molecular Species: | HBA: 2 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 5.12 | CX LogD: 5.12 |
Aromatic Rings: 0 | Heavy Atoms: 18 | QED Weighted: 0.46 | Np Likeness Score: 0.67 |
1. (2013) Agent for inhibiting odor of pyrazine derivatives, |
Source(1):